Cargando…

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant

Immunodeficient individuals often rely on donor-derived immunoglobulin (Ig) replacement therapy (IGRT) to prevent infections. The passive immunity obtained by IGRT is limited and reflects the state of immunity in the plasma donor population at the time of donation. The objective of the current study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindahl, Hannes, Klingström, Jonas, Da Silva Rodrigues, Rui, Christ, Wanda, Chen, Puran, Ljunggren, Hans-Gustaf, Buggert, Marcus, Aleman, Soo, Smith, C. I. Edvard, Bergman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090539/ https://www.ncbi.nlm.nih.gov/pubmed/35538387 http://dx.doi.org/10.1007/s10875-022-01283-9

Ejemplares similares

SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
por: Lindahl, Hannes, et al.
Publicado: (2023)

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
por: Gao, Yu, et al.
Publicado: (2022)

Elevated CD21(low) B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
por: Bergman, Peter, et al.
Publicado: (2022)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
por: Bestas, Burcu, et al.
Publicado: (2015)

T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
por: Blixt, Lisa, et al.
Publicado: (2022)

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
por: Boulouis, Caroline, et al.
Publicado: (2022)

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
por: Chen, Puran, et al.
Publicado: (2023)

COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency
por: Lindahl, Hannes, et al.
Publicado: (2021)

Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses
por: Coertse, Jessica, et al.
Publicado: (2023)

Product Choice Affects Risk of False-Positive Hepatitis B Virus Serology During Immunoglobulin Replacement Therapy
por: Lindahl, Hannes, et al.
Publicado: (2023)

Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2020)

Orthohantaviruses belonging to three phylogroups all inhibit apoptosis in infected target cells
por: Solà-Riera, Carles, et al.
Publicado: (2019)

Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2
por: Solà-Riera, Carles, et al.
Publicado: (2020)

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023)

Correction: Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2021)

A Case of Fabry's Disease with Congenital Agammaglobulinemia
por: Lee, Ki-Yeol, et al.
Publicado: (2011)

Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
por: Quan, Phenix-Lan, et al.
Publicado: (2010)

X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia
por: Arroyo-Martinez, Yadis M, et al.
Publicado: (2020)

Autism in a Child With X-linked Agammaglobulinemia
por: Bied, Adam, et al.
Publicado: (2022)

Vegetative Skin Lesions in Patient with Bruton's Agammaglobulinemia
por: Fidanzi, Cristian, et al.
Publicado: (2023)

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
por: Healy, Katie, et al.
Publicado: (2022)

Induction of human immunoglobulin synthesis and secretion in somatic cell hybrids of mouse myeloma and human B lymphocytes from patients with agammaglobulinemia
Publicado: (1978)

The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement
por: Cavaliere, Filomena Monica, et al.
Publicado: (2017)

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Bergman, Peter, et al.
Publicado: (2021)

The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia
por: Almontasheri, Ali, et al.
Publicado: (2021)

Mutations of the Igβ gene cause agammaglobulinemia in man
por: Ferrari, Simona, et al.
Publicado: (2007)

INFECTIOUS AGAMMAGLOBULINEMIA: TRANSMISSION OF IMMUNODEFICIENCY WITH GRAFTS OF AGAMMAGLOBULINEMIC CELLS
por: Blaese, R. Michael, et al.
Publicado: (1974)

Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association
por: Lavrador, Vasco, et al.
Publicado: (2014)

Disseminated Spiroplasma apis Infection in Patient with Agammaglobulinemia, France
por: Etienne, Nicolas, et al.
Publicado: (2018)

Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia
por: Tan, Qi, et al.
Publicado: (2017)

Agammaglobulinemia: from X-linked to Autosomal Forms of Disease
por: Cardenas-Morales, Melissa, et al.
Publicado: (2021)

MAIT cell activation is associated with disease severity markers in acute hantavirus infection
por: Maleki, Kimia T., et al.
Publicado: (2021)

A Child with X-Linked Agammaglobulinemia and Enthesitis-Related Arthritis
por: Sukumaran, Sukesh, et al.
Publicado: (2011)

Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia
por: Vu, Quang Van, et al.
Publicado: (2014)

Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia
por: Sugimoto, Keisuke, et al.
Publicado: (2014)

Presentation of a case of Bruton type primary agammaglobulinemia in Guinea
por: Condé, Kaba, et al.
Publicado: (2020)

Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia
por: Shelyakin, Pavel V., et al.
Publicado: (2021)

Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients
por: Le Coz, Carole, et al.
Publicado: (2021)

X-Linked Agammaglobulinemia Leading to Chronic Obstructive Lung Disease
por: Bean, Paris, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gk9qhojphd296h4sh6lubrbm36